Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel, Potent and Non-addictive Analgesic of Combinations for Knee Replacement Moderate to Severe Pain Management

NCT05842733 is registered in ClinicalTrials.gov with Sinew Pharma Inc. as lead sponsor.

NCT NCT05842733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05842733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel, Potent and Non-addictive Analgesic of Combinations for Knee Replacement Moderate to Severe Pain Management
Lead sponsor
Sinew Pharma Inc.
Phase
Phase 2
Overall status
Unknown status
Start date
July 25, 2023
Completion date
December 31, 2024
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain, postoperative